PRKCB overexpression, as seen in our results, has been previously reported in advanced neurodegenerative stages [i.e., PD and Alzheimer’s disease (AD)] [73]. This evidence concerns the gene PRKCB and early-onset autosomal dominant Alzheimer disease.